Factors associated with self-reported depression and anxiety among students studying at CST during COVID-19 pandemic. by Kezang Tshering (9316764)

Medical care provision, depressive symptoms, and social and emotional aspects (2020 and 2021). by Lisa Kertzscher (14053712)

Subjects:

Regression analysis on longitudinal changes in depressive symptoms (<i>n</i> = 69). by Lisa Kertzscher (14053712)

Subjects:

Descriptive statistics for depressive symptoms at baseline. by Kelsey R. Landrum (13839742)

Subjects:

Level of depression and anxiety among participants with different socio-demographic characteristics. by Kezang Tshering (9316764)

Level of caregiver burden, depression, quality of life and correlation with caregiver burden. by Denis Tuttle (14059560)

Subjects:

Behaviors with a significant main effect or interaction. by Grace Hecker (18813445)

Subjects:

Descriptive statistics for depression. by Ben Carey (9962347)

Subjects:

Clinical significance of CD133 expression in primary colon cancer tissues. by Takeshi Kaida (6532907)

Subjects:

Between group differences in depression, anxiety and sleep quality. by Amy H. Amabile (4252009)

PRISMA flow diagram of study reports eligible for inclusion. by Fiona O’Donovan (12630898)

Clinical levels of depressive, anxiety trauma and fear of COVID-19 symptoms among nurses and the general population at T1 and T2. by Catarina Vitorino (18389351)

Significantly changed USSs in the sf3b1 mutants. by Bei Zhang (428038)

The significant correlations between clinical variables and short-term neuropsychological assessment scores in the short- and medium-term outcome cohort. by Lara Harris (8622870)

Symptoms of anxiety, depression, sleep disturbances and alcohol consumption. by Yannis Karrer (14203825)

Depression prevalence in patients with stroke. by Nipaporn Butsing (19470003)

“…<div><p>Background</p><p>Post-stroke depression (PSD) is a frequent problem in stroke patients, affecting their rehabilitation process and functional outcomes. …”

Prevalence of depression among patients with diabetes at MMRH. by Mussa R. Mussa (15306923)

Subjects:

Clinical significance of CD44V expression in primary colon cancer tissues. by Takeshi Kaida (6532907)

Subjects:

The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

“…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”

Depleted antibody secreting cells did not result in decreased donor specific antibody in non-sensitized animals. by Natalie M. Bath (6316517)

Subjects: